SUO 2017 Prostate Cancer

REVIEW UroToday

Viewing 1-20 of 64 articles

SUO 2017: MRI Fusion Biopsy is Associated with a Higher Rate of Pathologic Downgrading at Radical Prostatectomy

SUO 2017: Outcomes of Serial MRI/Ultrasound Fusion Targeted Biopsy

SUO 2017: The Role of Inguinal Lymph Node Dissection in Men with Urethral Squamous Cell Carcinoma

SUO 2017: The REASSURE ME Trial

SUO 2017: Surgical And Imaging Findings Of Neoadjuvant Enzalutamide And Androgen Deprivation Therapy For High Risk Prostate Cancer: An Initial Case Study For An Ongoing Clinical Trial

SUO 2017: Longitudinal Assessment Of Health-related Quality Of Life And Decisional Regret In Men With Localized Prostate Cancer

SUO 2017: Primary Focal Cryoablation For Low-, Intermediate- And High-risk Prostate Cancer

SUO 2017: Anterior Prostate Lesions and Prostate Cancer Diagnosed in African American Men

SUO 2017: The Effect of Agent Orange Exposure on Treatment Choice

SUO 2017: Testosterone Responders to Continuous Androgen Deprivation Therapy

SUO 2017: Contemporary Trends in Abiraterone and Enzalutamide Prescription by Provider Specialty

SUO 2017: Does Insurance Status Lead to a Delay in Therapy - Patient Presenting with Metastatic Prostate Cancer?

SUO 2017: The Utilization of Hormone Therapy and Chemotherapy

SUO 2017: 68 GA-PSMA PET/CT Versus MP-MRI For Locoregional Prostate Cancer Staging: Correlation With Final Histopathology

SUO 2017: Utilization of MRI and Genomic Markers in Surveillance and Treatment Selection Among Patients Diagnosed With Prostate Cancer

SUO 2017: Targeted Early Detection In Men At High Genetic Risk For Prostate Cancer

SUO 2017: BMI is Not a Risk Factor for Active Surveillance Progression

SUO 2017: Prostate Cancer Treatment Variation in Accountable Care Organizations

SUO 2017: Pharmacodynamic and Pharmacokinetic Neoadjuvant Study - Hedgehog Pathway Inhibitor Sonidegib

SUO 2017: Should Patients With Negative Multi-parametric MRI Avoid Prostate Biopsy?

1
2
3
4